Cerebral Ischemia Related to Isotretinoin;Venlafaxine-Induced Alopecia;Cognitive Dysfunction with Tolterodine;Retinal Artery Occlusion after Injection of Long-Acting Risperidone;Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis;Metabolic Effects of the Atypical Antipsychotics – an Editorial;Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor;Suicide Attempts Related to Antidepressant Medications

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the Food and Drug Administration's (FDA) MEDWATCH program (800-FDA-1088). If you have reported an interesting preventable ADR to MEDWATCH, please consider sharing the account with our readers. Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices in cooperation with the FDA's MEDWATCH Program and Temple University School of Pharmacy. ISMP is an FDA MEDWATCH partner.